The landscape of amyotrophic lateral sclerosis (ALS) drug development saw a significant surge in activity last year, with 60 new…
Browsing: ALS
Amyotrophic lateral sclerosis (ALS) has been a challenging disease to tackle in terms of drug development, with several setbacks in…
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating condition that affects the nerves responsible for…
Our approach is unique in that we are targeting regulatory T cells (Tregs) to reduce inflammation and slow disease progression.…
